港股異動 | 中國旭陽集團(1907.HK)漲逾5%逼近新高 料前4月淨利較上年中期大增超2.5倍
格隆匯5月26日丨中國旭陽集團(1907.HK)拉昇漲逾5%,盤中高見5.97港元逼近歷史高價,總市值超240億港元。中國旭陽集團24日公佈了盈喜,集團預期2021年前4個月淨利將較上一中期期間增長超過250%。是由於集團於本期間的焦炭平均售價上升;集團通過收購合併、運營管理服務等方式進一步持續擴充產能。業內人士稱,旭陽集團將迎來新一輪跨越發展,未來表現更值得期待。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.